Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ran Tur-Kaspa

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
International Journal of Molecular Sciences|May 16, 2019
25-Hydroxyvitamin D Inhibits Hepatitis C Virus Production in Hepatocellular Carcinoma Cell Line by a Vitamin D Receptor-Independent MechanismAmiram Ravid, Noa Rapaport, Assaf Issachar, et al.
Hepatology (Baltimore, Md.)|July 28, 2011
Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytesMeital Gal-Tanamy, Larisa Bachmetov, Amiram Ravid, et al.
Antiviral Research|February 5, 2008
Inhibition of hepatitis C virus RNA replicons by peptide aptamersAlla Trahtenherts, Meital Gal-Tanamy, Romy Zemel, et al.
Plos One|January 26, 2011
Engineered toxins "zymoxins" are activated by the HCV NS3 protease by removal of an inhibitory protein domainAssaf Shapira, Meital Gal-Tanamy, Limor Nahary, et al.
Clinical Transplantation|May 10, 2007
Serum globulin levels in predicting the extent of hepatic fibrosis in patients with recurrent post-transplant hepatitis C infectionHemda Schmilovitz-Weiss, Michal Cohen, Orit Pappo, et al.
Transplantation|March 22, 2002
Seroconversion after the addition of famciclovir therapy in a child with hepatitis B virus infection after liver transplantation who developed lamivudine resistanceRivka Shapira, Nilli Daudi, Athallia Klein, et al.
Journal of Clinical Gastroenterology|June 25, 2008
Sustained virologic response to treatment in 100% of patients recently infected, nosocomially, with HCV genotype 2Emanuel Sikuler, Ran Tur-Kaspa, Yonat Shemer-Avni, et al.
The American Journal of Gastroenterology|January 16, 2003
Cytokine gene polymorphisms in patients infected with hepatitis B virusZiv Ben-Ari, Eytan Mor, Orit Papo, et al.
Nutrients|March 29, 2023
Beneficial Effect of Vitamin D on Non-Alcoholic Fatty Liver Disease (NAFLD) Progression in the Zebrafish ModelLihi Grinberg, Fadwa Dabbah Assadi, Gideon Baum, et al.
The Israel Medical Association Journal : IMAJ|December 15, 2018
Transplantation of Livers from Old Donors: Pushing the Envelope Beyond the Seventh DecadeEviatar Nesher, Marius Braun, Sigal Eizner, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Sciences|May 16, 2019
25-Hydroxyvitamin D Inhibits Hepatitis C Virus Production in Hepatocellular Carcinoma Cell Line by a Vitamin D Receptor-Independent MechanismAmiram Ravid, Noa Rapaport, Assaf Issachar, et al.
Hepatology (Baltimore, Md.)|July 28, 2011
Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytesMeital Gal-Tanamy, Larisa Bachmetov, Amiram Ravid, et al.
Antiviral Research|February 5, 2008
Inhibition of hepatitis C virus RNA replicons by peptide aptamersAlla Trahtenherts, Meital Gal-Tanamy, Romy Zemel, et al.
Plos One|January 26, 2011
Engineered toxins "zymoxins" are activated by the HCV NS3 protease by removal of an inhibitory protein domainAssaf Shapira, Meital Gal-Tanamy, Limor Nahary, et al.
Clinical Transplantation|May 10, 2007
Serum globulin levels in predicting the extent of hepatic fibrosis in patients with recurrent post-transplant hepatitis C infectionHemda Schmilovitz-Weiss, Michal Cohen, Orit Pappo, et al.
Transplantation|March 22, 2002
Seroconversion after the addition of famciclovir therapy in a child with hepatitis B virus infection after liver transplantation who developed lamivudine resistanceRivka Shapira, Nilli Daudi, Athallia Klein, et al.
Journal of Clinical Gastroenterology|June 25, 2008
Sustained virologic response to treatment in 100% of patients recently infected, nosocomially, with HCV genotype 2Emanuel Sikuler, Ran Tur-Kaspa, Yonat Shemer-Avni, et al.
The American Journal of Gastroenterology|January 16, 2003
Cytokine gene polymorphisms in patients infected with hepatitis B virusZiv Ben-Ari, Eytan Mor, Orit Papo, et al.
Nutrients|March 29, 2023
Beneficial Effect of Vitamin D on Non-Alcoholic Fatty Liver Disease (NAFLD) Progression in the Zebrafish ModelLihi Grinberg, Fadwa Dabbah Assadi, Gideon Baum, et al.
The Israel Medical Association Journal : IMAJ|December 15, 2018
Transplantation of Livers from Old Donors: Pushing the Envelope Beyond the Seventh DecadeEviatar Nesher, Marius Braun, Sigal Eizner, et al.
Pageof 5